Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2015 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 17th Annual BIO CEO & Investor Conference

NEWARK, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Management will make a presentation on the Company's programs and operations at the 17th Annual BIO...
January 26, 2015 08:00 ET | Source: StemCells, Inc.

Stem Cells Inc. Posts Letter to Shareholders

NEWARK, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
December 18, 2014 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord Injury

NEWARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central...
December 02, 2014 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event

NEWARK, Calif., Dec. 2, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leader in the development of cell-based therapies for disorders of the central nervous system (CNS), hosted its first...
November 20, 2014 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York

NEWARK, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
November 05, 2014 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results

NEWARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), which pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
November 03, 2014 17:25 ET | Source: StemCells, Inc.

StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York

NEWARK, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
October 07, 2014 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury

NEWARK, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell based therapies for the treatment of disorders of the central...
October 01, 2014 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 2014 Stem Cell Meeting on the Mesa

NEWARK, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations...
September 04, 2014 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 16th Annual Rodman & Renshaw Global Investment Conference

NEWARK, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 16th Annual Rodman & Renshaw Global Investment Conference...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right